Wednesday, February 13, 2013

• Theravance Narrows Y/Y LossZacks (Wed, Feb 13)
• Theravance's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Feb 13)

Tuesday, February 12, 2013

• Theravance Earnings: Here’s Why Investors are Not Excited Nowat Wall St. Cheat Sheet (Tue, Feb 12)
• THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online (Tue, Feb 12)
• Theravance Reports Fourth Quarter and Full Year 2012 Financial ResultsMarketwired (Tue, Feb 12)

Monday, February 11, 2013

• 5 Stocks Poised to Pop on Bullish Earningsat TheStreet (Mon, Feb 11)

Friday, February 8, 2013

• Has GlaxoSmithKline Become the Perfect Stock?at Motley Fool (Fri, Feb 8)

Monday, February 4, 2013

• 2 Biotech Stocks With Upcoming Catalystsat Seeking Alpha (Mon, Feb 4)

Thursday, January 31, 2013

• Theravance to Present at the Leerink Swann Global Healthcare Conference 2013Marketwired (Thu, Jan 31)
• Foresite Capital raises $100M to invest in late-stage healthcare companiesat bizjournals.com (Thu, Jan 31)

Wednesday, January 30, 2013

• Tupperware Fundamentals Deemed Solid and 4 Stock Analyses Attracting Attentionat Wall St. Cheat Sheet (Wed, Jan 30)

Tuesday, January 29, 2013

• Theravance to Report Fourth Quarter and Full Year 2012 Financial Results on February 12, 2013Marketwired (Tue, Jan 29)

Monday, January 28, 2013

• Theravance Winds up Public OfferingZacks (Mon, Jan 28)

Friday, January 25, 2013

• THERAVANCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial ObligatEDGAR Online (Fri, Jan 25)
• Which Biotech Company Will Be Bought Out Next?at Motley Fool (Fri, Jan 25)
• Boehringer’s Lung Drug’s Benefits Questionedat Bloomberg (Fri, Jan 25)

Thursday, January 24, 2013

• Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated NotesMarketwired (Thu, Jan 24)

Wednesday, January 23, 2013

• THERAVANCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements andEDGAR Online (Wed, Jan 23)

Tuesday, January 22, 2013

• Theravance Announces Exercise by Underwriters of Option to Purchase Additional $37.5 Million Convertible Subordinated NotesMarketwired (Tue, Jan 22)

Saturday, January 19, 2013

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Sat, Jan 19)

Thursday, January 17, 2013

• Theravance Announces Pricing of Convertible Subordinated Notes OfferingMarketwired (Thu, Jan 17)
• Theravance to Offer NotesZacks (Thu, Jan 17)

Wednesday, January 16, 2013

• THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 16)
• Theravance, Inc. to Offer $250 Million Convertible Subordinated Notes Due 2023Marketwired (Wed, Jan 16)
• Litespeed Management’s Best Stock Picksat Motley Fool (Wed, Jan 16)

Add THRX News to My Yahoo!